Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Anaplastic changes associated with p53 gene mutation in differentiated thyroid carcinoma after insufficient radioactive iodine (131I) therapy.

Sera N, Ashizawa K, Ando T, Ide A, Abe Y, Usa T, Tominaga T, Ejima E, Hayashi T, Shimokawa I, Eguchi K.

Thyroid. 2000 Nov;10(11):975-9.

PMID:
11128725
2.

The likely transformation of papillary thyroid carcinoma into anaplastic carcinoma during postoperative radioactive iodine-131 therapy: report of a case.

Shingu K, Kobayashi S, Yokoyama S, Fujimori M, Asanuma K, Ito KI, Hama Y, Maruyama M, Kusama R, Amano J.

Surg Today. 2000;30(10):910-3.

PMID:
11059731
3.

Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma.

Lin JD, Tsang NM, Huang MJ, Weng HF.

Jpn J Clin Oncol. 1997 Aug;27(4):244-7.

4.

[Seven cases of brain metastasis from papillary thyroid carcinoma].

Ikekubo K, Hino M, Ito H, Hirao K, Ueshima M, Tanaka T, Kobayashi H, Ishihara T, Kurahachi H.

Kaku Igaku. 2000 Jul;37(4):349-57. Japanese.

PMID:
10965656
5.

Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine.

Pacini F, Cetani F, Miccoli P, Mancusi F, Ceccarelli C, Lippi F, Martino E, Pinchera A.

World J Surg. 1994 Jul-Aug;18(4):600-4.

PMID:
7725751
6.

Selective postoperative radioactive iodine treatment of thyroid carcinoma.

McHenry C, Jarosz H, Davis M, Barbato AL, Lawrence AM, Paloyan E.

Surgery. 1989 Dec;106(6):956-8; discussion 958-9.

PMID:
2588122
7.

[Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].

Miyamoto S, Kasagi K, Endo K, Iida Y, Hidaka A, Hatabu H, Konishi J.

Nihon Igaku Hoshasen Gakkai Zasshi. 1991 Jul 25;51(7):810-21. Japanese.

PMID:
1891347
8.

Transformation of p53-positive papillary thyroid carcinoma to anaplastic carcinoma of the liver following postoperative radioactive iodine-131 therapy.

Takeshita Y, Takamura T, Minato H, Misu H, Ando H, Yamashita T, Ikeda H, Nakanuma Y, Kaneko S.

Intern Med. 2008;47(19):1709-12.

9.

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Mazzaferri EL, Jhiang SM.

Am J Med. 1994 Nov;97(5):418-28. Erratum in: Am J Med 1995 Feb;98(2):215.

PMID:
7977430
10.

Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation.

Lin JD, Chao TC, Huang MJ, Weng HF, Tzen KY.

Am J Clin Oncol. 1998 Feb;21(1):77-81.

PMID:
9499265
11.
12.

Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.

Grünwald F, Menzel C, Fimmers R, Zamora PO, Biersack HJ.

J Nucl Med. 1996 Dec;37(12):1962-4.

13.

[Prospective therapy study in differentiated thyroid carcinoma].

Gemsenjäger E, Heitz P, Martina B.

Schweiz Med Wochenschr. 1995 Nov 18;125(46):2226-36. Review. German.

PMID:
8525342
14.

Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.

Chen PV, Osborne R, Ahn E, Avitia S, Juillard G.

Ear Nose Throat J. 2009 Jul;88(7):E01.

PMID:
19623515
15.

Effectiveness of preoperative radioactive iodine (131I) therapy for locally advanced papillary thyroid cancer: a case report.

Shingu K, Kobayashi S, Yokoyama S, Shimizu T, Kasuga Y, Fujimori M, Ito K, Hama Y, Amano J.

Thyroid. 1998 Dec;8(12):1113-6.

PMID:
9920366
16.

Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.

Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C.

J Nucl Med. 1996 Apr;37(4):598-605.

17.

[Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].

Ono Y, Yamamoto Y, Nishiyama Y, Nakano S, Takahashi K, Kawasaki Y, Satoh K, Ohkawa M, Tanabe M.

Kaku Igaku. 2000 Nov;37(6):661-70. Japanese.

PMID:
11193452
18.

Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.

Park HM, Perkins OW, Edmondson JW, Schnute RB, Manatunga A.

Thyroid. 1994 Spring;4(1):49-54.

PMID:
8054861
19.

Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?

Proye CA, Dromer DH, Carnaille BM, Gontier AJ, Goropoulos A, Carpentier P, Lefebvre J, Decoulx M, Wemeau JL, Fossati P, et al.

World J Surg. 1992 Jul-Aug;16(4):640-5; discussion 645-6.

PMID:
1384244
20.

The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma.

Pelikan DM, Lion HL, Hermans J, Goslings BM.

Clin Endocrinol (Oxf). 1997 Dec;47(6):713-20.

PMID:
9497879
Items per page

Supplemental Content

Support Center